Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113158766 | 11315876 | 6 | F | 20150615 | 20160722 | 20150728 | 20160728 | EXP | JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-046728 | BRISTOL MYERS SQUIBB | 70.00 | YR | F | Y | 0.00000 | 20160728 | CN | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
113158766 | 11315876 | 1 | PS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, Q3WK | 2 | MG/KG | Y | 125554 | 2 | MG/KG | SOLUTION FOR INJECTION | Q3W | |||
113158766 | 11315876 | 2 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 2 | MG/KG | Y | 125554 | 2 | MG/KG | SOLUTION FOR INJECTION | ||||
113158766 | 11315876 | 3 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 2 | MG/KG | Y | 125554 | 2 | MG/KG | SOLUTION FOR INJECTION | ||||
113158766 | 11315876 | 4 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 2 | MG/KG | Y | 125554 | 2 | MG/KG | SOLUTION FOR INJECTION | ||||
113158766 | 11315876 | 5 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 2 | MG/KG | Y | 125554 | 2 | MG/KG | SOLUTION FOR INJECTION | ||||
113158766 | 11315876 | 6 | SS | NIVOLUMAB | NIVOLUMAB | 1 | Intravenous drip | 2 MG/KG, UNK | 2 | MG/KG | Y | 125554 | 2 | MG/KG | SOLUTION FOR INJECTION | ||||
113158766 | 11315876 | 7 | SS | AZULFIDINE | SULFASALAZINE | 1 | Oral | 500 MG, BID | U | 0 | 500 | MG | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
113158766 | 11315876 | 1 | Malignant melanoma |
113158766 | 11315876 | 7 | Rheumatoid arthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
113158766 | 11315876 | HO |
113158766 | 11315876 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
113158766 | 11315876 | Herpes zoster | |
113158766 | 11315876 | Inappropriate schedule of drug administration | |
113158766 | 11315876 | Musculoskeletal pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
113158766 | 11315876 | 1 | 20150610 | 20150610 | 0 | |
113158766 | 11315876 | 2 | 20150701 | 20150701 | 0 | |
113158766 | 11315876 | 3 | 20150803 | 20150803 | 0 | |
113158766 | 11315876 | 4 | 20151109 | 20151109 | 0 | |
113158766 | 11315876 | 5 | 20151207 | 20151207 | 0 | |
113158766 | 11315876 | 6 | 20160113 | 20160113 | 0 | |
113158766 | 11315876 | 7 | 200705 | 0 |